These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6141623)

  • 1. Beneficial effect of somatostatin on galactosamine induced liver injury.
    Limberg B; Kommerell B
    Regul Pept; 1983 Nov; 7(3):187-93. PubMed ID: 6141623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of somatostatin on galactosamine-induced liver injury.
    Limberg B; Kommerell B
    Klin Wochenschr; 1986; 64 Suppl 7():64-5. PubMed ID: 2882052
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum release of hepatic calcium-binding protein regucalcin by liver injury with galactosamine administration in rats.
    Isogai M; Oishi K; Yamaguchi M
    Mol Cell Biochem; 1994 Jul; 136(1):85-90. PubMed ID: 7854335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of prednisolone on the development of the galactosamine hepatitis of young and old rats (author's transl)].
    Platt D; Leinweber B; Förster L; Förster K
    Aktuelle Gerontol; 1976 Jun; 6(6):267-78. PubMed ID: 14531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylprednisolone injection via the portal vein suppresses inflammation in acute liver failure induced in rats by lipopolysaccharide and d-galactosamine.
    Higuchi N; Kato M; Kotoh K; Kohjima M; Aishima S; Nakamuta M; Fukui Y; Takayanagi R; Enjoji M
    Liver Int; 2007 Dec; 27(10):1342-8. PubMed ID: 17900243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ursodeoxycholic acid on biochemical parameters, hepatocyte proliferation and liver histology in galactosamine hepatitis in the rat.
    Rudi J; Schlenker T; Raedsch R; Waldherr R; Zorn M; Stremmel W
    Res Exp Med (Berl); 1995; 195(5):309-15. PubMed ID: 8579639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galactosamine-induced acute liver injury in rats reduces hepatic alpha-tocopherol transfer protein production.
    Takenaka A; Kita A; Ikeya M; Arai H; Igarashi K
    J Nutr Sci Vitaminol (Tokyo); 2007 Aug; 53(4):366-71. PubMed ID: 17934244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of nicotinamide, tryptophan, and methionine upon galactosamine-induced effects in the liver.
    Kröger H; Grätz R; Museteanu C; Haase J
    Arzneimittelforschung; 1981; 31(6):987-93. PubMed ID: 6455126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of the pretreatment and treatment with RhIL-11 on acute liver failure induced by D-galactosamine.
    Nie XH; Han T; Ha FU; Liang N; Wang SH; Zhu ZY; Xiang HL
    Eur Rev Med Pharmacol Sci; 2014; 18(8):1142-50. PubMed ID: 24817287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum alpha-fetoprotein. A prognostic indicator of liver-cell necrosis and regeneration following experimental injury by galactosamine in rats.
    Sell S; Stillman D; Gochman N
    Am J Clin Pathol; 1976 Nov; 66(5):847-53. PubMed ID: 62510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of the liver protecting compound ES 914 on D-galactosamine induced experimental hepatitis in the rat].
    Wegmann A; Chariatte N; Renker H; Dittrich A
    Arzneimittelforschung; 1979; 29(1):68-70. PubMed ID: 582121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic studies in experimental liver disease resulting from D(+)-galactosamine administration.
    Record CO; Alberti KG; Williamson DH
    Biochem J; 1972 Nov; 130(1):37-44. PubMed ID: 4655444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihepatotoxic activity of a quantified Desmodium adscendens decoction and D-pinitol against chemically-induced liver damage in rats.
    Magielse J; Arcoraci T; Breynaert A; van Dooren I; Kanyanga C; Fransen E; Van Hoof V; Vlietinck A; Apers S; Pieters L; Hermans N
    J Ethnopharmacol; 2013 Mar; 146(1):250-6. PubMed ID: 23291573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary wheat gluten alleviates the elevation of serum transaminase activities in D-galactosamine-injected rats.
    Manabe A; Cheng CC; Egashira Y; Ohta T; Sanada H
    J Nutr Sci Vitaminol (Tokyo); 1996 Apr; 42(2):121-32. PubMed ID: 8780970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of hepatotoxicity by macrophages in the liver.
    Shiratori Y; Kawase T; Shiina S; Okano K; Sugimoto T; Teraoka H; Matano S; Matsumoto K; Kamii K
    Hepatology; 1988; 8(4):815-21. PubMed ID: 2839405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of green tea extract on galactosamine-induced hepatic injury in rats].
    Hayashi M; Yamazoe H; Yamaguchi Y; Kunitomo M
    Nihon Yakurigaku Zasshi; 1992 Nov; 100(5):391-9. PubMed ID: 1464398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective effect of polyriboinosinic acid-polyribocytidylic acid against the occurrence of galactosamine-induced liver cell injury in rat.
    Sakakibara S; Shibayama Y; Ueda I; Kagamiyama H
    Experientia; 1983 Feb; 39(2):174-6. PubMed ID: 6832294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Galactosamine hepatitis: injury to the plasma membrane of hepatic cells following administration of D-galactosamine].
    Reutter W; Bachmann W
    Verh Dtsch Ges Inn Med; 1971; 77():1177-8. PubMed ID: 5155984
    [No Abstract]   [Full Text] [Related]  

  • 19. Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 improves acute liver injury induced by D-galactosamine in rats.
    Lv LX; Hu XJ; Qian GR; Zhang H; Lu HF; Zheng BW; Jiang L; Li LJ
    Appl Microbiol Biotechnol; 2014 Jun; 98(12):5619-32. PubMed ID: 24639205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of fasting on galactosamine induced hepatitis in experimental animals.
    Pickering RW
    Arzneimittelforschung; 1977; 27(10):1992-6. PubMed ID: 579109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.